| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| MARGOLIN YAEL | Director | C/O SCINAI IMMUNOTHERAPEUTICS LTD., JERUSALEM BIOPARK, 2ND FLOOR, JERUSALEM, ISRAEL | /s/ Amir Reichman, Attorney-in-Fact | 18 Mar 2026 | 0001868637 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | SCNI | American Depositary Shares | 18 Mar 2026 | Ordinary shares, no par value per share ("Ordinary Shares") | 200,000 | Direct | F1, F2 | |||||||
| holding | SCNI | Stock Option (right to buy) | 18 Mar 2026 | Ordinary Shares | 1,720,000 | $0.005000 | Direct | F3 | ||||||
| holding | SCNI | Stock Option (right to buy) | 18 Mar 2026 | Ordinary Shares | 8,000,000 | $0.005000 | Direct | F4 | ||||||
| holding | SCNI | Stock Option (right to buy) | 18 Mar 2026 | Ordinary Shares | 48,200,000 | $0.000400 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | Represents 50 American Depositary Shares, which are convertible at any time into 200,000 Ordinary Shares, at the holder's election and have no expiration date. |
| F2 | The Ordinary Shares are represented by American Depositary Shares, each of which currently represents four thousand Ordinary Shares. |
| F3 | The option vests in one installment on August 24, 2027, subject to the Reporting Person's continued service through such date. |
| F4 | The option vests in three equal annual installments commencing August 24, 2024, subject to the Reporting Person's continued service through such dates. |
| F5 | The option vests in three equal annual installments commencing December 22, 2026, subject to the Reporting Person's continued service through such dates. |
Exhibit 24 - Power of Attorney.